Antifibrinolytic drugs for treating primary postpartum hemorrhage
Emergencias. 2020 Jun;32(3):203-205.
[Article in
English,
Spanish]
Affiliations
- 1 Clinical Trials Unit, London School of Hygiene & Tropical Medicine, Londres, Reino Unido.
- 2 Clinical Haematology, Oxford University Hospitals, John Radcliffe Hospital, Oxford, Reino Unido.
- 3 Clinical Trials Unit, London School of Hygiene & Tropical Medicine, Londres, Reino Unido. Division of Clinical Epidemiology, Medical Directorate, University Hospitals of Geneva, Ginebra, Suiza.
- 4 University Department of Obstetrics and Gynaecology, Fetal and Maternal Medicine Unit, Leicester Royal Infirmary, Leicester, Reino Unido.
No abstract available
MeSH terms
-
Antifibrinolytic Agents* / therapeutic use
-
Female
-
Humans
-
Postpartum Hemorrhage* / drug therapy
-
Pregnancy
-
Tranexamic Acid* / therapeutic use
Substances
-
Antifibrinolytic Agents
-
Tranexamic Acid